Lv1
100 积分 2024-04-08 加入
Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma
16小时前
已完结
TACE: A consistent and continuously evolving therapy for HCC
17小时前
已完结
The Value of no Evidence of Disease (NED) in Intermediate‐Stage Hepatocellular Carcinoma After TACE: A Real‐World Study
17小时前
已完结
Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targets
17小时前
已完结
Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization
14天前
已关闭
Machine learning and molecular subtyping reveal the impact of diverse patterns of cell death on the prognosis and treatment of hepatocellular carcinoma
21天前
已完结
Predictive value of circulating immune cell changes in response to PD-1 blockade and TKI therapy in patients with hepatocellular carcinoma
21天前
已完结
Predictive value of circulating immune cell changes in response to PD-1 blockade and TKI therapy in patients with hepatocellular carcinoma
21天前
已完结
Preoperative Transarterial Chemoembolization for Resectable Single Hepatocellular Carcinoma: A Single-Center Cohort Study
28天前
已完结
Real-world treatment patterns and outcomes for patients with advanced hepatocellular carcinoma initially treated with PD-1 inhibitors
1个月前
已完结
皖公网安备34019202002308
